MedPath

EVOXAC

Approved
Approval ID

bf6bebde-81ef-4a49-bd8b-2b7444f7adbf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 2, 2011

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CEVIMELINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-859
Application NumberNDA020989
Product Classification
M
Marketing Category
C73594
G
Generic Name
CEVIMELINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateAugust 2, 2011
FDA Product Classification

INGREDIENTS (4)

CEVIMELINE HYDROCHLORIDEActive
Quantity: 30 mg in 1 1
Code: P81Q6V85NP
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EVOXAC - FDA Drug Approval Details